Ro 24-7429 Uses, Dosage, Side Effects and more

Ro 24-7429 is under investigation in clinical trial NCT00002314 (A Study of Ro 24-7429 in Patients With Hiv-related Kaposi's Sarcoma).

Trade Name Ro 24-7429
Generic Ro 24-7429
Type
Formula C14H13ClN4
Weight Average: 272.74
Monoisotopic: 272.0828741
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share